Related Experiment Video
Updated: Aug 9, 2026
12:43
Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
Published on: January 6, 2014
[Dendrite cell-based cancer vaccines--clinical application]
Inge Marie Svane1, Annika Berntsen, Redas Trepiakas
1Amtssygehuset i Herlev, Onkologisk og Haematologisk Afdeling, og Københavns Universitet, Panum Instituttet, Herlev. inge.m.svane@dadlnet.dk
Ugeskrift for Laeger
|April 6, 2006
Summary
Dendritic cell (DC) vaccination shows promise as a cancer immunotherapy by activating the immune system. Further research is needed to optimize this experimental treatment for better patient responses.
Area of Science:
- Immunology
- Oncology
- Vaccine Development
Context:
- Dendritic cell (DC)-based vaccination represents a novel immunotherapy strategy for cancer treatment.
- Over 1,000 cancer patients have participated in preclinical and clinical trials involving DC vaccination.
Purpose:
- To explore the potential of DC vaccination in cancer treatment.
- To assess the ability of DC vaccines to activate the immune system against cancer cells.
- To evaluate the clinical response rates in patients receiving DC vaccination.
Summary:
- DC vaccination aims to harness the immune system to combat cancer.
- Clinical trials indicate that DC vaccination can stimulate an anti-cancer immune response.
- A subset of patients have demonstrated clinical benefits from this experimental therapy.
Impact:
- DC vaccination offers a specific immunotherapy approach for cancer patients.
- The findings support the continued investigation and refinement of DC vaccine strategies.
- Optimizing DC vaccine design is crucial for improving therapeutic efficacy in oncology.
Related Concept Videos
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...